Cargando…
Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836896/ https://www.ncbi.nlm.nih.gov/pubmed/32533990 http://dx.doi.org/10.1016/j.diabres.2020.108268 |
| _version_ | 1783642844651585536 |
|---|---|
| author | Singh, Awadhesh Kumar Singh, Ritu |
| author_facet | Singh, Awadhesh Kumar Singh, Ritu |
| author_sort | Singh, Awadhesh Kumar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7836896 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78368962021-01-26 Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19? Singh, Awadhesh Kumar Singh, Ritu Diabetes Res Clin Pract Commentary Elsevier B.V. 2020-07 2020-06-10 /pmc/articles/PMC7836896/ /pubmed/32533990 http://dx.doi.org/10.1016/j.diabres.2020.108268 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Singh, Awadhesh Kumar Singh, Ritu Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19? |
| title | Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19? |
| title_full | Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19? |
| title_fullStr | Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19? |
| title_full_unstemmed | Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19? |
| title_short | Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19? |
| title_sort | is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and covid-19? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836896/ https://www.ncbi.nlm.nih.gov/pubmed/32533990 http://dx.doi.org/10.1016/j.diabres.2020.108268 |
| work_keys_str_mv | AT singhawadheshkumar ismetforminaheadintheraceasarepurposedhostdirectedtherapyforpatientswithdiabetesandcovid19 AT singhritu ismetforminaheadintheraceasarepurposedhostdirectedtherapyforpatientswithdiabetesandcovid19 |